Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47) (Q30412106)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47) |
scientific article |
Statements
1 reference
Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47) (English)
1 reference
Craig L Slingluff
1 reference
Kimberly A Chianese-Bullock
1 reference
Gina R Petroni
1 reference
Kerrington R Molhoek
1 reference
David L Brautigan
1 reference
Amber L Shada
1 reference
Mark E Smolkin
1 reference
Walter C Olson
1 reference
Alison Gaucher
1 reference
Cheryl Murphy Chase
1 reference
William W Grosh
1 reference
Geoffrey R Weiss
1 reference
Aubrey G Wagenseller
1 reference
Anthony J Olszanski
1 reference
Lainie Martin
1 reference
Sofia M Shea
1 reference
Gulsun Erdag
1 reference
Jeffrey E Gershenwald
1 reference
Michael J Weber
1 reference
25 April 2013
1 reference
1 reference
3611-3620
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference